Imitation and innovation new biologics, biosimilars and biobetters
- 28 November 2016
- journal article
- research article
- Published by Taylor & Francis Ltd in Technology Analysis & Strategic Management
- Vol. 29 (3), 251-262
- https://doi.org/10.1080/09537325.2016.1254771
Abstract
Biopharmaceutical drugs are the future of the pharmaceutical industry. The United States is the world leader in the development of new biopharmaceutical products. These original new drugs, numbering close to 200, are now losing patent protection and imitators from several countries are entering the markets of comparable drugs, called biosimilars. Some companies are improving the original product, and these drugs are called biobetters. Even among the producers of biosimilars one finds different strategies, and these are linked to different government regulations concerning the approval of these products. Some biosimilar companies are aiming at developed-country markets (North America, the European Union and Japan), while other producers are targeting emerging, less-regulated markets. This introduction will present the dynamic picture of an industry in transition. The paper has a double aim: discuss the fuzzy frontier between imitation and innovation, and track the new contours of the pharmaceutical industry.Keywords
Funding Information
- SSHRC
- Canada Research Chairs
This publication has 36 references indexed in Scilit:
- Emerging Economy Copycats: Capability, Environment, and Strategy.Academy of Management Perspectives, 2011
- Appropriate business strategy for leaders and laggardsIndustrial and Corporate Change, 2011
- The cost of biopharmaceutical R&D: is biotech different?Managerial and Decision Economics, 2007
- Innovation, imitation, and new product performance: The case of ChinaIndustrial Marketing Management, 2006
- Assessing the Economics of BiogenericsJournal of Generic Medicines, 2005
- Imitation versus innovation: Lessons to be learned from the JapaneseOrganizational Dynamics, 1994
- THE ECONOMICS OF IMITATION*Scottish Journal of Political Economy, 1990
- Absorptive Capacity: A New Perspective on Learning and InnovationAdministrative Science Quarterly, 1990
- Architectural Innovation: The Reconfiguration of Existing Product Technologies and the Failure of Established FirmsAdministrative Science Quarterly, 1990
- First-mover advantagesStrategic Management Journal, 1988